Barak UpdatesHappeningsBreaking News

4 more Covid +ve patients die at SMCH in last 24 hours

5 in ventilation, 17 in oxygen support out of 26 active cases at SMCH

Jan. 25: There has been a gradual rise in the number of daily positive cases in Cachar district. The last 24 hours (5 PM on 24 January to 5 PM on 25 January) witnessed the death of 04 (01 brought dead) more Covid-19 positive patients at Silchar Medical College & Hospital (SMCH). This was informed by Dr Bhaskar Gupta, Vice Principal of SMCH on Tuesday evening.

The deceased were identified as:

  • Tulsi Das (23) from Srigouri in Karimganj district tested Covid positive and was admitted at SMCH at 12.43 PM on 23 January. The patient, however, breathed his last at 8.45 PM on 24 January, 2022. The patient was suffering from sepsis, acute respiratory distress syndrome.
  • Sushama Sinha (57) from Dholai in Cachar district tested Covid positive and was admitted at SMCH at 11.28 PM on 23 January. The patient passed away at 6.20 AM on 25 January, 2022. The patient was suffering from acute respiratory distress syndrome, acute kidney injury.
  • Santanu Nath (2 months & 24 days) from Dharmanagar in Tripura tested Covid positive and was brought to SMCH at 1.30 AM on 25 January. As per SMCH authorities, the patient was brought dead.
  • Titu Nayek (08 years), S/O Rajesh Nayek from Patherkandi in Karimganj district tested Covid positive and was admitted at SMCH at 3.43 AM on 24 January. The patient died at 10 AM on 25 January, 2022. The patient was suffering from severe anemia with CCF.

Dr Bhaskar Gupta, Vice Principal of SMCH informed that till 5 PM on 25 January, there were 26 Covid-19 active patients at Silchar Medical College. Further, 05 patients were put under ventilator support, and 17 in oxygen support. In the last 24 hours, 03 Covid positive patients were admitted at SMCH and 03 were discharged. A total of 24 patients were detected positive in RAT at SMCH and 13 in RTPCR on Tuesday. Majority of them detected positive on Tuesday opted for home isolation.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

error: Content is protected !!
Close
Close

Adblock Detected

Please consider supporting us by disabling your ad blocker